FARALLON CAPITAL MANAGEMENT LLC 13D and 13G filings for PROGENICS PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-08 12:00 pm Sale | 2021-12-31 | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 0 0.000% | -8,500,000 (Position Closed) | Filing |
| 2021-02-12 6:42 pm Purchase | 2020-12-31 | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 8,500,000 9.800% | 250,000 (+3.03%) | Filing |